Vault-13

Exome Asset Management LLC

NEW YORK, NY · CIK 2011932 · 13F filing filed 2024-10-03

SEC-registered investment adviser since 2021 · limited liability company

As an employer

$112.3m reported value -3.8% vs Q1 2024
52positions
40.3%in top 10
28 new 6 added 10 reduced 29 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ELI LILLY & CO COM LLY LLY 9,700 $8.8m7.82% 7.82% UnchangedShares held: Q3 2023 —, Q4 2023 9.7k, Q1 2024 9.7k, Q2 2024 9.7k
2 SAREPTA THERAPEUTICS INC COM SRPT SRPT 32,900 $5.2m4.63% 4.63% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 32.9k
3 BEIGENE LTD SPONSORED ADR ONC ONC 33,200 $4.7m4.22% 4.22% ReducedShares held: Q3 2023 —, Q4 2023 12.8k, Q1 2024 36.8k, Q2 2024 33.2k -3.6k -3,600 -9.8%
4 TG THERAPEUTICS INC COM TGTX TGTX 251,600 $4.5m3.99% 3.99% AddedShares held: Q3 2023 —, Q4 2023 203.3k, Q1 2024 230.3k, Q2 2024 251.6k +21.3k +21,300 9.2%
5 THE CIGNA GROUP COM CI CI 12,200 $4.0m3.59% 3.59% ReducedShares held: Q3 2023 —, Q4 2023 15.3k, Q1 2024 15.3k, Q2 2024 12.2k -3.1k -3,100 -20.3%
6 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 84,790 $3.8m3.42% 3.42% ReducedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 87.8k, Q2 2024 84.8k -3.1k -3,056 -3.5%
7 INSMED INC COM PAR $.01 INSM INSM 56,800 $3.8m3.39% 3.39% ReducedShares held: Q3 2023 —, Q4 2023 61.5k, Q1 2024 71.7k, Q2 2024 56.8k -14.9k -14,900 -20.8%
8 AMGEN INC COM AMGN AMGN 11,800 $3.7m3.28% 3.28% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 11.8k
9 TRAVERE THERAPEUTICS INC COM TVTX TVTX 443,379 $3.6m3.24% 3.24% AddedShares held: Q3 2023 —, Q4 2023 84.0k, Q1 2024 362.5k, Q2 2024 443.4k +80.9k +80,892 22.3%
10 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 10,800 $3.0m2.69% 2.69% AddedShares held: Q3 2023 —, Q4 2023 13.2k, Q1 2024 7.9k, Q2 2024 10.8k +2.9k +2,900 36.7%
11 AVADEL PHARMACEUTICALS PLC COM SHS AVDL AVDL 209,092 $2.9m2.62% 2.62% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 209.1k
12 DEXCOM INC COM DXCM DXCM 25,928 $2.9m2.62% 2.62% AddedShares held: Q3 2023 —, Q4 2023 24.8k, Q1 2024 24.8k, Q2 2024 25.9k +1.1k +1,100 4.4%
13 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 839,472 $2.9m2.60% 2.60% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 839.5k
14 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 6,358 $2.8m2.52% 2.52% UnchangedShares held: Q3 2023 —, Q4 2023 6.4k, Q1 2024 6.4k, Q2 2024 6.4k
15 DR REDDYS LABS LTD ADR RDY RDY 36,300 $2.8m2.46% 2.46% ReducedShares held: Q3 2023 —, Q4 2023 90.0k, Q1 2024 86.0k, Q2 2024 36.3k -49.7k -49,700 -57.8%
16 DISC MEDICINE INC COM IRON IRON 61,000 $2.7m2.45% 2.45% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 61.0k
17 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 20,000 $2.7m2.43% 2.43% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 20.0k
18 KURA ONCOLOGY INC COM KURA KURA 131,742 $2.7m2.42% 2.42% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 131.7k
19 MERUS N V COM MRUS MRUS 45,100 $2.7m2.38% 2.38% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 45.1k
20 MASIMO CORP COM MASI MASI 19,800 $2.5m2.22% 2.22% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 19.8k
21 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 274,900 $2.5m2.21% 2.21% UnchangedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 274.9k, Q2 2024 274.9k
22 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 488,135 $2.4m2.17% 2.17% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 488.1k
23 GUARDANT HEALTH INC COM GH GH 79,000 $2.3m2.03% 2.03% UnchangedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 79.0k, Q2 2024 79.0k
24 CABALETTA BIO INC COM CABA CABA 300,200 $2.2m2.00% 2.00% NewShares held: Q3 2023 —, Q4 2023 46.7k, Q1 2024 0, Q2 2024 300.2k
25 ARVINAS INC COM ARVN ARVN 82,400 $2.2m1.95% 1.95% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 82.4k
26 NATERA INC COM NTRA NTRA 18,650 $2.0m1.80% 1.80% UnchangedShares held: Q3 2023 —, Q4 2023 18.6k, Q1 2024 18.6k, Q2 2024 18.6k
27 BIOHAVEN LTD COM BHVN BHVN 57,800 $2.0m1.79% 1.79% NewShares held: Q3 2023 —, Q4 2023 45.5k, Q1 2024 0, Q2 2024 57.8k
28 BRIDGEBIO PHARMA INC COM BBIO BBIO 78,907 $2.0m1.78% 1.78% AddedShares held: Q3 2023 —, Q4 2023 65.1k, Q1 2024 48.8k, Q2 2024 78.9k +30.1k +30,100 61.7%
29 FULCRUM THERAPEUTICS INC COM FULC FULC 302,700 $1.9m1.67% 1.67% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 302.7k
30 APELLIS PHARMACEUTICALS INC COM APLS APLS 46,900 $1.8m1.60% 1.60% NewShares held: Q3 2023 —, Q4 2023 7.2k, Q1 2024 0, Q2 2024 46.9k
31 ALPHATEC HLDGS INC COM NEW ATEC ATEC 162,100 $1.7m1.51% 1.51% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 162.1k
32 ABCELLERA BIOLOGICS INC COM ABCL ABCL 514,900 $1.5m1.36% 1.36% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 514.9k
33 ZAI LAB LTD ADR ZLAB ZLAB 86,700 $1.5m1.34% 1.34% AddedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 65.3k, Q2 2024 86.7k +21.4k +21,400 32.8%
34 PLIANT THERAPEUTICS INC COM PLRX PLRX 124,000 $1.3m1.19% 1.19% NewShares held: Q3 2023 —, Q4 2023 49.6k, Q1 2024 0, Q2 2024 124.0k
35 REZOLUTE INC COM NEW RZLT RZLT 282,400 $1.2m1.08% 1.08% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 282.4k
36 ALVOTECH ORDINARY SHARES ALVO ALVO 99,000 $1.2m1.07% 1.07% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 99.0k
37 GOSSAMER BIO INC COM GOSS GOSS 1,127,699 $1.0m0.90% 0.90% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 1.1m
38 ELEVATION ONCOLOGY INC COM COM 369,322 $997.2k0.89% 0.89% UnchangedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 369.3k, Q2 2024 369.3k
39 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 21,700 $986.0k0.88% 0.88% NewShares held: Q3 2023 —, Q4 2023 27.6k, Q1 2024 0, Q2 2024 21.7k
40 SYROS PHARMACEUTICALS INC COM NEW SYRS SYRS 159,175 $821.3k0.73% 0.73% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 159.2k
41 QUANTERIX CORP COM QTRX QTRX 59,650 $788.0k0.70% 0.70% UnchangedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 59.6k, Q2 2024 59.6k
42 Q32 BIO INC COM QTTB QTTB 43,865 $787.4k0.70% 0.70% ReducedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 65.0k, Q2 2024 43.9k -21.2k -21,156 -32.5%
43 VYNE THERAPEUTICS INC COM COM 353,434 $696.3k0.62% 0.62% ReducedShares held: Q3 2023 —, Q4 2023 118.1k, Q1 2024 415.4k, Q2 2024 353.4k -62.0k -62,000 -14.9%
44 PMV PHARMACEUTICALS INC COM PMVP PMVP 358,400 $580.6k0.52% 0.52% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 358.4k
45 APREA THERAPEUTICS INC COM NEW APRE APRE 137,174 $558.3k0.50% 0.50% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 137.2k
46 TECTONIC THERAPEUTIC INC COM TECX TECX 32,389 $533.4k0.47% 0.47% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 32.4k
47 ADAGENE INC ADS ADAG ADAG 150,876 $461.8k0.41% 0.41% ReducedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 155.4k, Q2 2024 150.9k -4.5k -4,507 -2.9%
48 I MAB SPONSORED ADS NBP NBP 271,400 $453.2k0.40% 0.40% ReducedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 325.8k, Q2 2024 271.4k -54.4k -54,362 -16.7%
49 PROCAPS GROUP SA SHS PROCF PROCF 126,901 $321.1k0.29% 0.29% NewShares held: Q3 2023 —, Q4 2023 126.9k, Q1 2024 0, Q2 2024 126.9k
50 HILLEVAX INC COM COM 18,000 $260.3k0.23% 0.23% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 18.0k
51 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 50,700 $173.4k0.15% 0.15% ReducedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 60.9k, Q2 2024 50.7k -10.2k -10,200 -16.8%
52 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 75,300 $103.2k0.09% 0.09% UnchangedShares held: Q3 2023 —, Q4 2023 75.3k, Q1 2024 75.3k, Q2 2024 75.3k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
ALPINE IMMUNE SCIENCES INC NVLS NVLS 117,000 $4.6m117.0k shares
AVIDITY BIOSCIENCES INC RNA RNA 135,169 $3.4m135.2k shares
CELLDEX THERAPEUTICS INC NEW CLDX CLDX 71,100 $3.0m71.1k shares
GERON CORP GERN GERN 886,800 $2.9m886.8k shares
AEROVATE THERAPEUTICS INC 98,485 $2.9m98.5k shares
MORPHOSYS AG 154,800 $2.8m154.8k shares
KRYSTAL BIOTECH INC KRYS KRYS 14,700 $2.6m14.7k shares
TARSUS PHARMACEUTICALS INC TARS TARS 66,300 $2.4m66.3k shares
INOZYME PHARMA INC 273,413 $2.1m273.4k shares
RHYTHM PHARMACEUTICALS INC RYTM RYTM 45,603 $2.0m45.6k shares
EXACT SCIENCES CORP EXAS EXAS 26,700 $1.8m26.7k shares
CYTOKINETICS INC CYTK CYTK 26,008 $1.8m26.0k shares
REGENXBIO INC RGNX RGNX 84,470 $1.8m84.5k shares
BIOGEN INC BIIB BIIB 8,200 $1.8m8.2k shares
OCULAR THERAPEUTIX INC OCUL OCUL 193,600 $1.8m193.6k shares
AGIOS PHARMACEUTICALS INC AGIO AGIO 59,902 $1.8m59.9k shares
PENUMBRA INC PEN PEN 7,353 $1.6m7.4k shares
OLEMA PHARMACEUTICALS INC OLMA OLMA 143,400 $1.6m143.4k shares
ARROWHEAD PHARMACEUTICALS IN ARWR ARWR 55,700 $1.6m55.7k shares
TERNS PHARMACEUTICALS INC 227,821 $1.5m227.8k shares
MARINUS PHARMACEUTICALS INC MRNS MRNS 163,100 $1.5m163.1k shares
INARI MED INC NARI NARI 30,100 $1.4m30.1k shares
INTRA-CELLULAR THERAPIES INC ITCI ITCI 20,300 $1.4m20.3k shares
SHOCKWAVE MED INC SWAV SWAV 4,000 $1.3m4.0k shares
REGULUS THERAPEUTICS INC RGLS RGLS 402,504 $1.2m402.5k shares